| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
January 17, 2005 |
|
|
| |
|
|
| |
|
|
|
IBC Life Sciences, Boston Convention & Exhibition Center
May 1-5, 2005
This year more than ever, if you work in oligonucleotide- or peptide-based therapeutics, you need to get behind-the-scenes scoop on what’s happening right now in the industry – and what will happen next. TIDES® 2005 showcases the enormous pipeline potential of both categories, as well as recent successes, current challenges and potential solutions. It also provides proven tactics on how to serve the needs of the multi-billion dollar diagnostics industry. Attend this event and learn about: big pharma’s perspective on the future of oligo-based therapeutics; novel technologies and commercialization strategies for therapeutics, diagnostics and research; supply chain – minimizing risk and improving economics; and updates on leading clinical and preclinical candidates from Eyetech, Cubist, Human Genome Sciences, Coley Pharmaceuticals and Corgentech – and more. To register for TIDES® 2005, or view full conference details, visit www.IBCLifeSciences.com/TIDES.
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
-
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
Phone 508-616-5550
Fax 508-616-5522
Email reg@ibcusa.com
Online www.IBCLifeSciences.com/TIDES
|
|
|
E-mail:
|
|
reg@ibcusa.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|